Company profile for TC BioPharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to develop and commercialize innovative cell-based products and to treat disease, improve patient health and Quality of Life. TC BioPharm is a privately-held, clinical-stage cell the...
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to develop and commercialize innovative cell-based products and to treat disease, improve patient health and Quality of Life. TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Maxim Park Parklands Way, Eurocentral Holytown, ML1 4WR
Telephone
Telephone
+44(0) 141 433 7557
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/18/3189932/0/en/CytoMed-Therapeutics-Completes-Acquisition-of-T-Cell-Technology-from-UK-to-Treat-Cancers-in-China-and-India.html

GLOBENEWSWIRE
18 Nov 2025

https://www.globenewswire.com/news-release/2025/10/14/3166116/0/en/CytoMed-makes-cash-bid-for-potential-acquisition-of-TC-BioPharm-Limited-s-relevant-assets.html

GLOBENEWSWIRE
14 Oct 2025

https://www.prnewswire.com/news-releases/tc-biopharm-announces-complete-response-in-minimal-residual-disease-mrd-patient-302478287.html

PR NEWSWIRE
11 Jun 2025

https://www.prnewswire.com/news-releases/tcbp-announces-transition-from-nasdaq-to-otc-markets-302408102.html

PR NEWSWIRE
21 Mar 2025

https://www.prnewswire.com/news-releases/tcbp-announces-outsourcing-initiatives-reducing-burn-rate-and-overhead-302403910.html

PR NEWSWIRE
18 Mar 2025

https://www.prnewswire.com/news-releases/tcbp-announces-non-binding-letter-of-intent-to-acquire-commercial-stage-ophthalmic-pharmaceutical-company-302393099.html

PR NEWSWIRE
05 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty